American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
Oaktree Acquisition Corp. III Life Sciences
$10.65
+0.00%
NASDAQ: OACC · 15-min delayed
$261.8MMarket cap
$7.3MNet income
OACCNASDAQ
2024IPO
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp III Life Sciences is a blank check company.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Net income
- $7.3M
- Total assets
- $203.1M
- Market cap
- $261.8M
Source: SEC EDGAR · updated Jun 8, 2026
FY 2025
Financial statements
Income statement
- Operating income
- -$1.2M
- Net income
- $7.3M
Balance sheet
- Total assets
- $203.1M
- Current assets
- $1.5M
- Total liabilities
- $8.3M
- Current liabilities
- $1.3M
- Shareholders’ equity
- -$6.8M
Cash flow
- Operating cash flow
- -$422.1K
- Investing cash flow
- $500.0K
- Financing cash flow
- -$77.9K
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
NASDAQ: OACC
$10.65
+0.00%
15-minute delayed · data by Polygon.io
Past year
$10.30
$10.73
52-week range
- Market cap
- $261.8M
- Shares outstanding
- 24.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 16, 2024
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Profitable — net income of $7.3M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Oaktree Acquisition Corp. III Life Sciences.
Write a review
Newsroom
News about Oaktree Acquisition Corp. III Life Sciences
News & sentiment via Polygon.io
Explore
Browse all →
